Clinical Trial Update: The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating selenium for treatment of secondary lymphedema in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Drugs mentioned

• Selenium (selenium)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Breast Neoplasms, Lymphedema | Phase 2 | Status: COMPLETED